HP&M Files Comments Opposing FDA’s Proposed LDT Rule
FDA Law Blog
DECEMBER 6, 2023
FDA tries to justify the proposed rule by claiming that LDTs present significant risks, and that the solution is to regulate them all as medical devices. Tests such as genetic testing of prospective parents, prenatal screening, cancer prognosis, and testing for rare diseases play a critical role in the health care system.
Let's personalize your content